Tibira Therapeutics, Inc. 4
4 · Tibira Therapeutics, Inc. · Filed May 6, 2015
Insider Transaction Report
Form 4
Brosgart Carol L
Director
Transactions
- Award
Stock Options (right to buy)
2015-05-04+4,332→ 8,664 totalExercise: $3.14Exp: 2020-11-30→ Common Stock (4,332 underlying) - Award
Stock Options (right to buy)
2015-05-04+4,332→ 12,996 totalExercise: $3.51Exp: 2023-02-06→ Common Stock (4,332 underlying) - Award
Stock Options (right to buy)
2015-05-04+18,956→ 31,952 totalExercise: $4.81Exp: 2024-04-27→ Common Stock (18,956 underlying) - Award
Stock Options (right to buy)
2015-05-04+4,332→ 4,332 totalExercise: $4.25Exp: 2020-02-24→ Common Stock (4,332 underlying)
Footnotes (4)
- [F1]Reporting Person received such stock option in exchange for a stock option to purchase Tobira Therapeutics, Inc. ("Tobira") common stock in connection with the merger of Tobira into Issuer (the "Merger"). Pursuant to the terms of the Merger agreement each Tobira stock option assumed will be determined by multiplying the number of options by the exchange ratio of 1.43 and rounding down to the nearest whole number.
- [F2]The shares are fully vested and exercisable at any time.
- [F3]These shares shall never vest or become exercisable.
- [F4]6,318 of the shares are vested and exercisable at any time. The remaining 12,638 shares will vest ratably over the next 32 months of continuous service beginning on June 1, 2015, subject to the terms of the Issuer's 2010 Stock Plan.